Drug Shortage Report for AA-IPRAVENT
Report ID | 152767 |
Drug Identification Number | 02126222 |
Brand name | APO-IPRAVENT SOLUTION - INH 250MCG/ML |
Common or Proper name | IPRAVENT |
Company Name | AA PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | IPRATROPIUM BROMIDE |
Strength(s) | 250MCG |
Dosage form(s) | SOLUTION |
Route of administration | INHALATION INHALATION |
Packaging size | 20 ML |
ATC code | R03BB |
ATC description | OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-01-10 |
Estimated end date | 2022-04-01 |
Actual end date | 2022-03-25 |
Shortage status | Resolved |
Updated date | 2022-03-28 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1165 CREDITSTONE ROAD VAUGHAN, ONTARIO CANADA L4K 4N7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2022-03-28 | French | Compare |
v5 | 2022-03-28 | English | Compare |
v4 | 2022-02-24 | French | Compare |
v3 | 2022-02-24 | English | Compare |
v2 | 2022-01-14 | French | Compare |
v1 | 2022-01-14 | English | Compare |
Showing 1 to 6 of 6